New Concept 2000 Sprl has been acquired by a private nursing home group
New Concept 2000 Sprl has been successfully sold to a private nursing home group as a consequence of the ongoing consolidation in the Belgian nursing home market. The main driver for this consolidation is stricter regulation and the accompanying need for capital expenditure.
Founded in 1998, New Concept 2000 Sprl owns three nursing homes—La Fontaine, La Colombière and La Roseraie—operating one of them, La Fontaine. In 2008, Wallogistic Sprl was created as a food catering and laundry services provider as well as a central purchasing unit, mainly for hygienic products. Its clients are almost exclusively these three nursing homes, but its scope of activity can be extended to third parties. In 2009, Gesvesenior Asbl was established and is responsible for operating La Colombière and La Roseraie. In total, the company operates more than 160 beds.
The acquirors are private investors who operate a nursing home group with approximately five entities in the Walloon region of Belgium.
The company Wallogistic was not included in the scope of the sale and therefore remains under the sellers’ ownership.
Oaklins’ team in Belgium acted as the exclusive M&A sell-side advisor to New Concept 2000 in this transaction.
联系交易团队
相关交易
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
更多信息Afric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
更多信息Xiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
更多信息